These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3013033)

  • 1. Essential fatty acid supplementation in tardive dyskinesia.
    Wolkin A; Jordan B; Peselow E; Rubinstein M; Rotrosen J
    Am J Psychiatry; 1986 Jul; 143(7):912-4. PubMed ID: 3013033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia.
    Vaddadi KS
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):67-70. PubMed ID: 1321448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihomo-gamma-linolenic acid, prostaglandins and dyskinesias.
    Costall B; Holmes SW; Kelly ME; Naylor RJ
    Prog Lipid Res; 1986; 25(1-4):629-32. PubMed ID: 2827191
    [No Abstract]   [Full Text] [Related]  

  • 4. Atopic dermatitis and disturbances of essential fatty acid and prostaglandin E metabolism.
    Melnik B; Plewig G
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):859-60. PubMed ID: 1666398
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.
    Vaddadi KS; Courtney P; Gilleard CJ; Manku MS; Horrobin DF
    Psychiatry Res; 1989 Mar; 27(3):313-23. PubMed ID: 2565585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind study of lecithin in the treatment of persistent tardive dyskinesia.
    Pérez-Cruet J; Menéndez I; Alvarez-Ghersi J; Falcón JR; Valderrábano O; Castro-Urrutia EC; Ifarraguerri C; Pérez LL
    Bol Asoc Med P R; 1981 Nov; 73(11):531-7. PubMed ID: 6121562
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism.
    Horrobin DF
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):71-7. PubMed ID: 1321449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.
    Santoli D; Zurier RB
    J Immunol; 1989 Aug; 143(4):1303-9. PubMed ID: 2545787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
    Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA
    Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 11. Naloxone may be beneficial in the treatment of tardive dyskinesia.
    Blum I; Munitz H; Shalev A; Roberts E
    Clin Neuropharmacol; 1984; 7(3):265-7. PubMed ID: 6386154
    [No Abstract]   [Full Text] [Related]  

  • 12. Clonidine trial in tardive dyskinesia. Therapeutic response, MHPG, and plasma DBH.
    Tripodianakis J; Markianos M
    Pharmacopsychiatry; 1986 Sep; 19(5):365-7. PubMed ID: 3534900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sodium valproate on tardive dyskinesia--revisited.
    Fisk GG; York SM
    Br J Psychiatry; 1987 Apr; 150():542-6. PubMed ID: 3117156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia].
    Karniol IG; Giampietro AC; Moura DS; Vilela WA; Oliveira MA; Zuardi AW
    Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-linolenic acid in diabetic neuropathy.
    Jamal GA; Carmichael H; Weir AI
    Lancet; 1986 May; 1(8489):1098. PubMed ID: 2871365
    [No Abstract]   [Full Text] [Related]  

  • 16. [Additional oral therapy of atopic dermatitis with unsaturated fatty acids].
    Meigel W; Dettke T; Meigel EM; Lenze U
    Z Hautkr; 1987; 62 Suppl 1():100-3. PubMed ID: 2894730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baclofen in the treatment of tardive dyskinesia.
    Nair NP; Yassa R; Ruiz-Navarro J; Schwartz G
    Am J Psychiatry; 1978 Dec; 135(12):1562-3. PubMed ID: 31097
    [No Abstract]   [Full Text] [Related]  

  • 18. Lithium in tardive dyskinesia.
    Simpson GM; Branchey MH; Lee JH; Voitashevsky A; Zoubok B
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Mar; 9(2):76-80. PubMed ID: 790411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of lithium treatment in established tardive dyskinesia.
    MacKay AV; Sheppard GP; Saha BK; Motley B; Johnson AL; Marsden CD
    Psychol Med; 1980 Aug; 10(3):583-7. PubMed ID: 7003639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.